Scott A Elman1, Cara Joyce2, Filippa Nyberg3, Fukumi Furukawa4, Mark Goodfield5, Minoru Hasegawa6, Branka Marinovic7, Jacek C Szepietowski8, Jan Dutz9, Victoria P Werth10, Joseph F Merola11. 1. Harvard Medical School, Boston, Massachusetts. 2. Department of Public Health Sciences, Loyola University, Chicago, Illinois. 3. Institution for Clinical Sciences, Karolinska Institutet at Danderyd Hospital, Stockholm, Sweden. 4. Department of Dermatology, Wakayama Medical University, Wakayama, Japan. 5. Department of Dermatology, Leeds General Infirmary, Leeds, United Kingdom. 6. Department of Dermatology, Division of Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan. 7. Department of Dermatology and Venereology, University Hospital Center Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia. 8. Department of Dermatology, Venereology, and Allergology, University of Medicine, Wroclaw, Poland. 9. Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada. 10. Philadelphia Department of Veterans Affairs Medical Center and Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania. 11. Harvard Medical School, Boston, Massachusetts; Division of Rheumatology, Departments of Dermatology and Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address: jfmerola@bwh.harvard.edu.
Abstract
BACKGROUND: No classification criteria currently exist for discoid lupus erythematosus (DLE), which has led to problematic heterogeneity in both observational and interventional research efforts. OBJECTIVES: We sought to develop DLE classification criteria based on consensus of international expert opinion of relevant stakeholders in the field. METHODS: Using a Delphi consensus process and nominal group techniques, potential items for classification criteria were generated. Experts ranked items in terms of their appropriateness and ability to discriminate DLE from other diagnoses, and items were subsequently eliminated using consensus exercises. RESULTS: A final list of 12 clinical and histopathologic items was generated for potential inclusion into a set of DLE classification criteria through a formal ongoing validation process. LIMITATIONS: The participants are predominantly composed of DLE experts in North America and Europe. CONCLUSION: This work represents a key step toward the development of formal DLE classification criteria.
BACKGROUND: No classification criteria currently exist for discoid lupus erythematosus (DLE), which has led to problematic heterogeneity in both observational and interventional research efforts. OBJECTIVES: We sought to develop DLE classification criteria based on consensus of international expert opinion of relevant stakeholders in the field. METHODS: Using a Delphi consensus process and nominal group techniques, potential items for classification criteria were generated. Experts ranked items in terms of their appropriateness and ability to discriminate DLE from other diagnoses, and items were subsequently eliminated using consensus exercises. RESULTS: A final list of 12 clinical and histopathologic items was generated for potential inclusion into a set of DLE classification criteria through a formal ongoing validation process. LIMITATIONS: The participants are predominantly composed of DLE experts in North America and Europe. CONCLUSION: This work represents a key step toward the development of formal DLE classification criteria.
Authors: Sara K Tedeschi; Sindhu R Johnson; Dimitrios T Boumpas; David Daikh; Thomas Dörner; Betty Diamond; Søren Jacobsen; David Jayne; Diane L Kamen; W Joseph McCune; Marta Mosca; Rosalind Ramsey-Goldman; Guillermo Ruiz-Irastorza; Matthias Schneider; Murray Urowitz; David Wofsy; Josef S Smolen; Raymond P Naden; Martin Aringer; Karen H Costenbader Journal: Ann Rheum Dis Date: 2019-01-28 Impact factor: 19.103
Authors: Sara K Tedeschi; Sindhu R Johnson; Dimitrios Boumpas; David Daikh; Thomas Dörner; David Jayne; Diane Kamen; Kirsten Lerstrøm; Marta Mosca; Rosalind Ramsey-Goldman; Corine Sinnette; David Wofsy; Josef S Smolen; Raymond P Naden; Martin Aringer; Karen H Costenbader Journal: Arthritis Care Res (Hoboken) Date: 2018-02-22 Impact factor: 4.794
Authors: Scott A Elman; Cara Joyce; Kara Braudis; Benjamin F Chong; Anthony P Fernandez; Fukumi Furukawa; Minoru Hasegawa; Hee Joo Kim; Sara J Li; Christine G Lian; Jacek C Szepietowski; Victoria P Werth; Joseph F Merola Journal: JAMA Dermatol Date: 2020-08-01 Impact factor: 10.282
Authors: Josef Symon S Concha; Aikaterini Patsatsi; Ann Marshak-Rothstein; Ming-Lin Liu; Animesh A Sinha; Lela A Lee; Joseph F Merola; Ali Jabbari; Johann E Gudjonsson; François Chasset; Paul Jarrett; Benjamin Chong; Lisa Arkin; Anthony P Fernandez; Marzia Caproni; Steven A Greenberg; Hee Joo Kim; David R Pearson; Alisa Femia; Ruth Ann Vleugels; David Fiorentino; Manabu Fujimoto; Joerg Wenzel; Victoria P Werth Journal: J Invest Dermatol Date: 2018-09-19 Impact factor: 8.551
Authors: Anna Berekméri; Ana Tiganescu; Adewonuola A Alase; Edward Vital; Martin Stacey; Miriam Wittmann Journal: Front Immunol Date: 2019-08-21 Impact factor: 8.786